Partial hepatectomy-induced regeneration accelerates reversion of liver fibrosis involving participation of hepatic stellate cells

Experimental Biology and Medicine

Volumn 233, Issue 7, 2008, Pages 827-839

  Suárez Cuenca, Juan A ^a   De Sánchez, Victoria Chagoya ^a   Aranda Fraustro, Alberto ^b   Sánchez Sevilla, Lourdes ^a   Martínez PÉrez, Lidia ^a   Hernández MuÑoz, Rolando ^a  

^a INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

^b INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

Collagen metabolism; Experimental cirrhosis; Hepatic stellate cells; Liver mitochondria; MMPs; Partial hepatectomy; TIMPs

Indexed keywords

COLLAGEN; COLLAGENASE; COLLAGENASE 3; GELATINASE A; GELATINASE B; PROLINE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; MESSENGER RNA;

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CELL REGENERATION; COLLAGEN DEGRADATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; LIVER CELL; LIVER FIBROSIS; LIVER REGENERATION; MALE; MORPHOMETRICS; NONHUMAN; PARTIAL HEPATECTOMY; RAT; STELLATE CELL; WISTAR RAT; ANIMAL; LIVER; LIVER CIRRHOSIS; LIVER RESECTION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

RATTUS; RATTUS NORVEGICUS; SUIDAE;

ANIMALS; CELL PROLIFERATION; COLLAGEN; EXTRACELLULAR MATRIX; HEPATECTOMY; HEPATOCYTES; LIVER; LIVER CIRRHOSIS; LIVER REGENERATION; MALE; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; RATS; RATS, WISTAR; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 47749098930     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/0709-RM-247     Document Type: Article

References (64)

1. Chang C, Werb Z. The many faces of metalloproteases: cell growth, Invasion, angiogenesis and metastasis. Trends Cell Biol 11:S37-S43, 2001.
2. Shuppan D, Ruehl M, Somasundaram R, Hahn EG. Matrix as modulator of hepatic fibrogenesis. Semin Liver Dis 21:351-372, 2001.
3. Martínez-Hernández A, Sebastían-Amenta P. The extracellular matrix in hepatic regeneration. FASEB J 9:1401-1410, 1995.
4. Rojkind M, Greenwel P. Animal models of liver fibrosis. Adv Vet Sci Comp Med 37:333-335, 1993.
5. Chanda S, Mangipudy RS, Warbritton A, Bucci TJ, Mehendale HM. Stimulated hepatic tissue repair underlies heteroprotection by thioace-tamide against acetaminophen-induced lethality. Hepatology 21:477-486, 1995.
6. Rojkind M, Greenwel P. Pathophysiology of liver fibrosis. Oxford Textbook of Clinical Hepatology. Edited by Mclntyre N, Benhamou J-P, Bircher J, Rizzeto M and Rodes J. New York, Oxford Medical Publication, p. 375-380, 1991.
7. Friedman SL. Molecular Regulation of hepatic fibrosis, and integrated cellular response to tissue injury. Minireview. J Biol Chem 275:2247-2250, 2000.
8. Pinzani M. Rombouts K, Colagrande S. Fibrosis in chronic liver diseases: diagnosis and management. J Hepatol 42:S22-S36, 2005.
9. Gines P, Cardenas A, Arroyo V, Rodes J. Management of cirrhosis and ascites. N Engl J Med 350:1646-1654, 2004.
10. Albanis E, Friedman SL. Hepatic fibrosis. Pathogenesis and principles of therapy. Clin Liver Dis 5:315-334, 2001.
11. Arthur MJP. Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis. Am J Physiol Gastrointest Liver Physiol 279:G245-G249, 2000.
12. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 115:209-218, 2005.
13. Bruck R, Genina O, Aeed H, Alexiev R, Nagler A, Avni Y, Pines M. Halofuginone to prevent and treat thioacetamide-induced liver fibrosis in rats. Hepatology 33:379-386, 2001.
14. Andiran F, Kilinc K, Renda N, Ayhan A, Tanyel FC. Lipid peroxidation and extracellular matrix in normal and cirrhotic rat livers following 70% hepatectomy. Hepatogastroenterology 50:805-808, 2003.
15. Kanta J, Chlumská A. Regenerative ability of hepatocytes is inhibited in early stages of liver fibrosis. Physiol Res 40:453-158, 1991.
16. Rozga J, Foss A, Alumets J, Ahren B, Jeppsson B, Bengmark S. Liver cirrhosis in rats: regeneration and assessment of the role of phenobarbital. J Surg Res 51:329-335, 1991.
17. Hashimoto M, Watanabe G. Functional restoration of cirrhotic liver after partial hepatectomy in the rat. Hepatogastroenterology 52:897-902, 2005.
18. Assy N, Hussein O, Khalil A, Luder A, Szvalb S, Paizi M, Spira G. The beneficial effect of aspirin and enoxaparin on fibrosis progression and regenerative activity in a rat model of cirrhosis. Dig Dis Sci 52:1187-1193, 2007.
19. Ozawa S, Uchiyama K, Nakamori M, Ueda K, Iwahashi M, Ueno H, Muragaki Y, Ooshima A, Yamaue H. Combination gene therapy of HGF and truncated type II TGF-beta receptor for rat liver cirrhosis after partial hepatectomy. Surgery 139:563-573, 2006.
20. Oe H, Kaido T, Furuyama H, Mori A, Imamura M. Simultaneous transfer of vascular endothelial growth factor and hepatocyte growth factor genes effectively promotes liver regeneration after hepatectomy in cirrhotic rats. Hepatogastroenterology 51:1641-1647, 2004.
21. Mohammed FF, Khokha R. Thinking outside the cell: proteases regulate hepatocyte division. Trends Cell Biol 15:555-563, 2005.
22. Roselli HT, Su M, Washington K, Kerins DM, Vaughan DE, Russell WE. Liver regeneration is transiently impaired in urokinase-deficient mice. Am J Physiol 275:G1472-G1479, 1998.
23. Issa R, Zhou X, Trim N, Millward-Sadler H, Krane S, Benyon C, Iredale J. Mutation in collagen-1 that confers resistance to the action of collagenase results in failure of recovery from CCl4-induced liver fibrosis, persistence of activated hepatic stellate cells, and diminished hepatocyte regeneration. FASEB J 17:47-49, 2003.
24. Mohammed FF, Pennington CJ, Kassiri Z, Rubin JS, Soloway PD, Ruther U, Edwards DR, Khokha, R. Metalloproteinase inhibitor TIMP-1 affects hepatocyte cell cycle via HGF activation in murine liver regeneration. Hepatology 41:857-867, 2005.
25. Tanaka Y, Nouchi T, Yamane M, Irie T, Miyakawa H, Sato C, Marumo F. Phenotypic modulation in lypocytes in experimental liver fibrosis. J Pathol 164:273-278, 1991.
26. Arthur MJ. Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C. Gastroenterology 122:1525-1528, 2002.
27. Rudin CM, Thompson CB. Apoptosis and disease: regulation and clinical relevance of programmed cell death. Annu Rev Med 40:267-281, 1997.
28. Paronetto F, Popper C. Chronic liver injury induced by immunologic reactions. Cirrhosis following immunization with heterologous sera. Am J Pathol 49:1087-1101, 1966.
29. Montfort I, Perez-Tamayo R, Alvizouri AM, Tello E. Collagenase of hepatocytes and sinusoidal liver cells in the reversibility of experimental cirrhosis of the liver. Virchows Arch B Cell Pathol Mol Pathol 59:281-289, 1990.
30. Zhao G, Nakano K, Chijiiwa K, Ueda J, Tanaka M. Inhibited activities in CCAAT/enhancer-binding protein, activating protein-1 and cyclins after hepatectomy in rats with thioacetamide-induced liver cirrhosis. Biochem Biophys Res Commun 292: 474-481, 2002.
31. Miyamoto M, Manabe N, Uchio K, Kuramitsu K, Tamura D. Characteristics of lectin staining patterns assessed by a modified sensitive thermo-method in rat livers with heterologous serum-induced fibrosis. J Vet Med Sci 60:953-960, 1998.
32. Higgins GM, Anderson RM. Experimental pathology of the liver: the restoration of liver of white rat following surgical removal. Arch Pathol 12:186-202, 1931.
33. Fujiwara K, Ogata I, Ohta Y, Hayashi S, Mishiro S, Takatsuki K, Sato Y, Yamada S, Hirata K, Oka H. Decreased collagen accumulation by a prolyl hydroxylase inhibitor in pig serum-induced fibrotic rat liver. Hepatology 8:804-807, 1988.
34. Hernández-Muñoz R, Díaz-Muñoz M, Suárez-Cuenca JA, Trejo-Solís C, López V, Sánchez-Sevilla L, Yañez L, Chagoya de Sánchez V. Adenosine reverses a preestablished CCl4-induced micronodular cirrhosis through enhancing collagenolytic activity and stimulating hepatocyte cell proliferation in rats. Hepatology 34:677-687, 2001.
35. 14C in collagen and non-collagenous proteins. Anal Biochem 57:1-7, 1974.
36. Hernández-Muñoz R, Díaz-Muñoz M, Chagoya de Sánchez V. Adenosine partially prevents cirrhosis induced by carbon tetrachloride in rats. Hepatology 12:242-248, 1990.
37. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Bio-chem 162:156-159, 1987.
38. Villarreal FJ, Dillmann WH. Cardiac hypertrophy-induced changes in mRNA levels of TGFb, fibronectin, and collagen. Am J Physiol 262: H1860-H1866, 1992.
39. Knittel H, Mehde M, Grundmann B, Scharf JG, Ramadori G. Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat. Histochem Cell Biol 113:443-453, 2000.
40. Laemmli UK. Cleavage of structural proteins during the assembly of the headbacteriophage T4. Nature 227:680-685, 1970.
41. Michalopoulos GK, DeFrances M. Liver regeneration. Adv Biochem Engin Biotechnol 93:101-134, 2005.
42. Rojkind M, Rojkind MH, Cordero-Hernandez J. In vivo collagen synthesis and deposition in fibrotic and regenerating rat livers. Coll Relat Res 3:335-347, 1983.
43. Hernández-Muñoz R, Díaz-Muñoz M, Chagoya de Sánchez V. Possible role of cell redox state on collagen metabolism in carbon tetrachloride-induced cirrhosis as evidenced by adenosine administration to rats. Biochim Biophys Acta 1200:93-99, 1994.
44. Hernández-Muñ Sánchez-Sevilla L, Martínez- Gómez A, Dent MA. Changes in mitochondrial adenine nucleotides and in permeability transition in two models of rat liver regeneration. Hepatology 37:842-851, 2003.
45. Rockey DC. Hepatic fibrosis, stellate cells, and portal hypertension. Clin Liver Dis 10:459-479, 2006.
46. Siegmund SV, Dooley S, Brenner DA. Molecular mechanisms of alcohol-induced hepatic fibrosis. Dig Dis 23:264-274, 2005.
47. Bedossa P, Paradis V. Liver extracellular matrix in health and disease. J Pathol 200:504-515, 2003.
48. Zheng WD, Zhang LJ, Shi MN, Chen ZX, Chen YX, Huang YH, Wang XZ. Expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 in hepatic stellate cells during rat hepatic fibrosis and its intervention by IL-10. World J Gastroenterol 11:1753-1758, 2005.
49. Goldberg GI, Strongin A, Collier IE, Genrich LT, Marmer BL. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J Biol Chem 267:4583-4591, 1992.
50. Serandour AL, Loyer P, Garnier D, Courselaud B, Theret N, Glaise D, Guguen-Guillouzo C, Corlu A. TNFalpha-mediated extracellular matrix remodeling is required for multiple division cycles in rat hepatocytes. Hepatology 41:478-486, 2005.
51. Kim TH, Mars WM, Stolz DB, Petersen BE, Michalopoulos GK. Extracellular matrix remodeling at the early stages of liver regeneration in the rat. Hepatology 26:896-904, 1997.
52. Morimoto T, Isselhard W. Absence of mitochondrial enhancement in the remnant liver after partial hepatectomy in cirrhotic rats. Res Exp Med (Berl) 192:89-97, 1992.
53. Chijiiwa K, Nakano K, Kameoka N, Nagai E, Tanaka M. Proliferating cell nuclear antigen, plasma fibronectin, and liver regeneration rate after seventy percent hepatectomy in normal and cirrhotic rats. Surgery 116: 544-549, 1994.
54. Mitsue S, Hamanoue M, Tanabe G, Ogura Y, Yoshidome S, Aikou T, Nakamura T. Expression of HGF and TGF-β1 mRNA after partial hepatectomy in rats with liver cirrhosis. Surg Today 25:237-243, 1995.
55. Masson S, Scotté M, François A, Coeffier M, Provot F, Hiron M, Ténière P, Fallu J, Salier JP, Daveau M. Changes in growth factor in cytokine mRNA levels after hepatectomy in rat with CCl4-induced cirrhosis. Am J Physiol 277:G838-G846, 1999.
56. Kaido T, Yoshikawa A, Seto S, Yamaoka S, Sato M, Ishii T, Imamura M. Portal branch ligation with a continuous hepatocyte growth factor supply makes extensive hepatectomy possible in cirrhotic rats. Hepatology 28:756-760, 1998.
57. Oe H, Kaido T, Furuyama H, Mori A, Imamura M. Simultaneous transfer of vascular endothelial growth factor and hepatocyte growth factor genes effectively promotes liver regeneration after hepatectomy in cirrhotic rats. Hepatogastroenterology 51:1641-1647, 2004.
58. Ozawa S, Uchiyama K, Nakamori M, Ueda K, Iwahashi M, Ueno H, Muragaki Y, Ooshima A, Yamaue H. Combination gene therapy of HGF and truncated type II TGF-β receptor for rat liver cirrhosis after partial hepatectomy. Surgery 139:563-573, 2006.
59. Bedossa P, Paradis V. Liver extracellular matrix in health and disease. J Pathol 200:504-515, 2003.
60. Henderson NC, Mackinnon AC, Farnworth SL, Poirier F, Russo FP, Iredale JP, Haslett C, Simpson KJ, Sethi T. Galectin-3 regulates myofibroblast activation and hepatic fibrosis. Proc Natl Acad Sci USA 103:5060-5065, 2006.
61. Mabuchi A, Mullaney I, Sheard PW, Hessian PA, Mallard BL, Tawadrous MN, Zimmermann A, Senoo H, Wheatley AM. Role of hepatic stellate cell/hepatocyte interaction and activation of hepatic stellate cells in the early phase of liver regeneration in the rat. J Hepatol 40:910-916, 2004.
62. Aguilar-Delfin I, Lopez-Barrera F, Hernandez-Munoz R. Selective enhancement of lipid peroxidation in plasma membrane in two experimental models of liver regeneration: partial hepatectomy and acute CC14 administration. Hepatology 24:657-662, 1996.
63. Trejo-Solis C, Chagoya de Sanchez V, Aranda-Fraustro A, Sanchez-Sevilla L, Gomez-Ruiz C, Hernandez-Munoz R. Inhibitory effect of vitamin e administration on the progression of liver regeneration induced by partial hepatectomy in rats. Lab Invest 83:1669-1679, 2003.
64. Vollmar B, Siegmund S, Richter S, Menger MD. Microvascular consequences of Kupffer cell modulation in rat liver fibrogenesis. J Pathol 189:85-91, 1999.